 |
|
|
|
|
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AzurRx BioPharma, Inc.
| | | | | Phone: | (646) 699-7855 | | Year Established: | 2014 | | Main Contact: | Martin Krusin, VP, Finance and Business Development | | | | Other Contacts: | Mathieu Schué, Ph.D., Head of Laboratory
Yves Leblond, Ph.D., Director of R&D
Luc Lebreton, PhD, R&D, Programs Director
Philippe Jais, MD, Ph.D., Director of Medical Research and Translational Medicine
Thijs Spoor, President & CEO
Daniel Dupret, Ph.D., CSO
George Harb, MD, MPH, Head Clinical Development
| | | | Company Description | | AzurRx BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company’s lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infection. The company is headquartered in New York, NY, with scientific operations based in Langlade, France. | |
|
|
|
|
|
|
|
